about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
Company profile
Ticker
DVA
Exchange
Website
CEO
Javier Rodriguez
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DAVITA HEALTHCARE PARTNERS INC., DAVITA INC, TOTAL RENAL CARE HOLDINGS INC
SEC CIK
Corporate docs
Subsidiaries
Aberdeen Dialysis, LLC • Adair Dialysis, LLC • Afton Dialysis, LLC • Ahern Dialysis, LLC • Alenes Dialysis, LLC • Alomie Dialysis, LLC • Alterra Dialysis, LLC • American Fork Dialysis, LLC • American Medical Insurance, Inc. • Amery Dialysis, LLC ...
IRS number
510354549
DVA stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
10 Apr 24
10-K
2023 FY
Annual report
14 Feb 24
8-K
DaVita Inc. 4th Quarter 2023 Results
13 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
DaVita Inc. 3rd Quarter 2023 Results
7 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
DaVita Inc. 2nd Quarter 2023 Results
3 Aug 23
8-K
Departure of Directors or Certain Officers
25 Jul 23
8-K
Departure of Directors or Certain Officers
13 Jul 23
8-K
Amendments to Articles of Incorporation or Bylaws
8 Jun 23
Transcripts
DVA
Earnings call transcript
2023 Q4
13 Feb 24
DVA
Earnings call transcript
2023 Q3
7 Nov 23
DVA
Earnings call transcript
2023 Q2
3 Aug 23
DVA
Earnings call transcript
2023 Q1
8 May 23
DVA
Earnings call transcript
2022 Q4
22 Feb 23
DVA
Earnings call transcript
2022 Q3
28 Oct 22
DVA
Earnings call transcript
2022 Q2
2 Aug 22
DVA
Earnings call transcript
2022 Q1
6 May 22
DVA
Earnings call transcript
2021 Q4
11 Feb 22
DVA
Earnings call transcript
2021 Q3
29 Oct 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
89.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 492 |
Opened positions | 80 |
Closed positions | 38 |
Increased positions | 152 |
Reduced positions | 172 |
13F shares | Current |
---|---|
Total value | 7.32 tn |
Total shares | 78.40 mm |
Total puts | 2.93 mm |
Total calls | 1.01 mm |
Total put/call ratio | 2.9 |
Largest owners | Shares | Value |
---|---|---|
BRK.A Berkshire Hathaway Inc. - Ordinary Shares | 36.10 mm | $3.41 tn |
Vanguard | 6.18 mm | $583.73 bn |
BLK Blackrock | 4.91 mm | $464.20 bn |
STT State Street | 2.47 mm | $233.45 bn |
LSV Asset Management | 1.78 mm | $167.57 bn |
IVZ Invesco | 1.67 mm | $157.61 bn |
Millennium Management | 1.47 mm | $138.56 bn |
MS Morgan Stanley | 1.22 mm | $115.10 bn |
Geode Capital Management | 1.20 mm | $113.56 bn |
Citadel Advisors | 1.07 mm | $101.56 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Berry Christopher Michael | Common Stock | Grant | Acquire A | No | No | 0 | 3,659 | 0.00 | 12,127 |
15 Mar 24 | Schoppert Wendy Lee | Common Stock | Grant | Acquire A | No | No | 0 | 366 | 0.00 | 820 |
15 Mar 24 | Berg Charles | Common Stock | Grant | Acquire A | No | No | 0 | 366 | 0.00 | 18,277 |
15 Mar 24 | Adam H Schechter | Common Stock | Grant | Acquire A | No | No | 0 | 366 | 0.00 | 2,625 |
News
Philips' Zenition 30 to Boost Image-Guided Surgeries
23 Apr 24
Philips (PHG) Boosts Patient Monitoring With SmartQare Deal
9 Apr 24
Diagnosing the Economy Ahead of World Health Day: 6 Picks
5 Apr 24
Globus Medical (GMED) Gains From New Launches Amid Macro Issues
4 Apr 24
The American Diabetes Association And DaVita Announce Expansion Of A Multi-Year Collaboration, Focused On Advancing Chronic Disease Prevention, Specifically Addressing Diabetes And Chronic Kidney Disease
11 Mar 24
Press releases
Garry Menzel joins GHO Capital as Operating Partner
23 Apr 24
DaVita's Global Operations Powered by 100% Renewable Energy
22 Apr 24
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call
17 Apr 24
DaVita Announces Dennis Pullin to its Board of Directors
10 Apr 24
The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On
11 Mar 24